Kabsons Industri (524675)
TurnaroundScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹30.97 |
| Market Cap | ₹56.92 Cr |
| P/E Ratio | 18.26 |
| ROCE | 8.07% |
| ROE | 10.02% |
| Dividend Yield | 0% |
| Profit Growth | 1,000% |
| Debt/Equity | — |
| Sales Growth | -0.63% |
| 52-Week Range | ₹11.25 — ₹30.97 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹7.91 |
Strengths
- Latest quarter shows ₹11 Cr sales with ₹1 Cr net profit, implying a healthy nearly 9% net margin for a trading business.
- Piotroski F-Score of 6/9 suggests reasonable financial health across profitability, leverage, and efficiency metrics.
- ROE of 10.02% and ROCE of 8.07% are positive, indicating the company is generating some return on capital.
- Reported profit growth of 1,000% signals a possible recovery from a weak base, though sustainability is unproven.
Concerns
- Sales growth is -0.63%, so the top line is not expanding; the profit spike appears to come from a low base rather than business growth.
- Valuation is demanding: P/E of 18.26 and P/B of 3.92 for a distributor with only 10% ROE and book value ₹7.91 leave little margin of safety.
- Zero dividend yield means investors get no income support while waiting for capital appreciation.
- Promoter holding and debt/equity are not disclosed, making it difficult to assess governance and balance-sheet risk.
AI Analysis
Looking at Kabsons Industri, the first thing I ask is: what kind of business am I buying? It is a trading and distribution company, and in my experience, that rarely comes with a durable moat. The numbers confirm my caution. Sales growth is -0.63%, so the top line is flat to shrinking. The reported 1,000% profit growth looks exciting until you remember that a huge percentage jump can come from a tiny previous base. With market cap ₹57 Cr and P/E 18.26, the market is paying 18 times earnings for a no-moat distributor. That is not a Graham bargain. Book value is ₹7.91, so I am paying 3.92 times book for a 10% ROE. That combination—high price-to-book, moderate return on equity—offers little margin of safety. The latest quarter does show ₹11 Cr sales and ₹1 Cr profit, which is roughly a 9% net margin; that is nice for a quarter, but I need years of consistent evidence, not one print. The Piotroski score of 6/9 is acceptable but not outstanding, and the zero dividend yield means I get no cash return while I wait. With the stock at ₹30.97, the top of its 52-week range, the market has already marked it up. I prefer to buy a good business at a fair price, but this is an average business at an optimistic price. I will wait for either a much lower price or sustained improvement in sales and return on capital before writing a cheque.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer